Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Parkinson's drug could be repurposed to save sight of millions
In a major scientific breakthrough, a drug used to treat Parkinson's and related diseases may be able to delay or prevent macular degeneration, the most common form of blindness among older Americ...
Bill Ackman hints at possible Valeant Pharmaceuticals sale
Embattled Valeant Pharmaceuticals may be coming around to the idea of selling itself.
Google, American Heart Association Announce Joint Research Effort
ORLANDO, Fla.
India's Dr Reddy's hit by FDA warning, shares fall 15 percent
Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, has received a "warning letter" from U.
New compound can reverse cataract
A team of scientists has identified a new chemical that can be used in eye drops to reverse cataracts which are a leading cause of blindness worldwide.
Australian scientists identify way to target neuroblastoma cancer
CBL0137Melbourne.
TaiwanJ Pharmaceuticals Gains FDA Approval for Entering Phase 2 Clinical Study on Autoimmune Hepatitis, an Orphan Disease
HSINCHU, Taiwan I November 05, 2015 I TaiwanJ Pharmaceuticals (6549.
Gilead's new four-in-one HIV pill, Genvoya, wins US approval
Federal regulators have approved a new four-in-one combination pill to treat HIV, the virus that causes AIDS.
New vaccine candidate shows great promise at fighting respiratory syncytial virus
Johns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise ...
GlaxoSmithKline bags an FDA OK for its asthma drug with eyes on a respiratory turnaround
GlaxoSmithKline ($GSK) won FDA approval for an antibody designed to treat severe asthma, leading a pack of drugmakers at work on similar therapies as it seeks to bolster its respiratory busine...
CASI Pharmaceuticals Announces First Patient Dosed In Phase 2 Trial For ENMD-2076 In Fibrolamellar Carcinoma (FLC)
ROCKVILLE, MD, USA I November 4, 2015 I CASI Pharmaceuticals, Inc.
NephroGenex Announces Successful Results from Toxicity Study of Intravenous Pyridorin
RALEIGH, NC, USA I November 4, 2015 I NephroGenex, Inc.
641
642
643
644
645
646
647
648
649
